ArticleJournal of Cancer2020

A Novel Pre-treatment Model Predicting Risk of Developing Refractoriness to Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma.

Keshu Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.